Sedative, hypnotic or anxiolytic use, unspecified with intoxication delirium
ICD-10 F13.921 is a billable code used to indicate a diagnosis of sedative, hypnotic or anxiolytic use, unspecified with intoxication delirium.
F13.921 refers to a condition characterized by the use of sedatives, hypnotics, or anxiolytics that leads to intoxication delirium. This condition is often seen in individuals who misuse these substances, which can include benzodiazepines, barbiturates, and other medications that depress the central nervous system. Intoxication delirium manifests as confusion, altered consciousness, and cognitive impairment, which can pose significant risks to the individual’s safety and well-being. The diagnosis is typically made based on clinical evaluation, including a thorough history of substance use, physical examination, and assessment of mental status. Treatment may involve supportive care, monitoring, and potentially the use of medications to manage symptoms. Understanding the nuances of this diagnosis is crucial for effective treatment and management of substance use disorders, as well as for accurate coding and billing practices.
Detailed history of substance use, mental status examination, and treatment plan.
Patients presenting with acute confusion and a history of sedative use.
Consideration of co-occurring mental health disorders and their impact on treatment.
Comprehensive assessment of substance use patterns and withdrawal symptoms.
Patients undergoing detoxification from sedatives with delirium.
Monitoring for withdrawal symptoms and potential complications.
Used when a patient is admitted for management of intoxication delirium.
Comprehensive history and examination, including mental status assessment.
Psychiatric evaluation may be necessary for accurate diagnosis.
F13.921 includes the presence of intoxication delirium, while F13.920 does not specify any acute symptoms or cognitive impairment.
